We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3 High-Yield Dividend Stocks For The Next Bear Market: GlaxoSmithKline plc, Pearson plc And G4S plc

Should you buy shares in GlaxoSmithKline plc (LON:GSK), Pearson plc (LON:PSON) & G4S plc (LON:GFS) for their dividends?

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

When stock markets go awry, high yield stocks tend to outperform the broader market. The high-yielding dividend stocks that perform best in a downturn are so-called defensive ones. These are stocks in companies that provide goods and services always needed throughout the business cycle, enabling them to generate stable profits year after year.

Here are three high-yield stocks that could protect your portfolio in a bear market.

Should you buy Pearson Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Controversial

GlaxoSmithKline (LSE: GSK) may be a controversial pick given its poor earnings trend. But as healthcare needs are continually rising, GSK remains a big growth opportunity. And despite recent weak results, it maintains a strong competitive position and has robust free cash flow generation.

Early signs of recovery are also beginning to show, with quarterly sales figures highlighting strong growth from its new pharmaceutical products, especially its new respiratory drug line-up including recently launched Breo, Anoro and Incruse. New products account for just £2bn in annual sales, but with continued sales growth and additional launches, sales could rise to £6bn by 2018.

Meanwhile, investors are being handsomely rewarded for their patience, with shares in the pharma giant currently yielding 5.5%. There’s one major short-term negative: with the dividend being frozen at 80p per share for 2016 and 2017, there’s no dividend growth for at least two years.

Transition

Pearson (LSE: PSON) is going through a rough patch, reporting a 2% drop in adjusted operating profits in 2015 and management giving a weak set of guidance figures for 2016. Adjusted operating profits are expected to come between £580m and £620m in 2016, which at the mid-point implies a decline of 13% on the previous year.

There are causes for optimism though. Pearson‘s competitive position is strong, and cyclical and policy factors are mainly to blame for recent weakness. This included a buoyant employment market in the US, which meant reduced college enrolment, and policy changes in the UK that lowered demand for its vocational course services.

The outlook in the longer term remains attractive. Pearson has significant exposure to growing markets in Brazil, China, India and South Africa, where it’s launching new products such as the New Student Experience. Its transition from print to digital would also likely be positive to its competitive position, given the advantage scale has on digital platforms.

With an annual dividend of 52p per share, Pearson yields 6%.

Market leader

Investor confidence in G4S (LSE: GFS) is near an all-time low, with the company seemingly embroiled in an endless list of controversies, ranging from overcharging of government contracts, human rights violations and abuse at a young offenders centre. But the company is still set to deliver strong underlying growth in revenues and earnings.

G4S remains global market leader in security services and against the backdrop of global economic uncertainty, demand for its services remains robust. In 2015, it secured new contract sales worth £2.4bn with retention rates near 90%. This shows the company has little trouble in winning new contracts even after recent scandals.

City analysts expect underlying EPS will grow 5.6% this year, to 15.2p per share. For 2017, earnings should climb another 9%, to 16.6p. This would put the shares on an attractive forward P/E of 12.2 and 11.2, respectively.

The stock’s 5.1% yield isn’t as big, but there’s potential for faster future dividend growth, given that earnings growth is set to accelerate.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Joyful mature couple having fun together enjoying vacation on city street. Two retired older people enjoying time together during autumn holidays or weekend getaway
Investing Articles

How much do you need in an ISA to target a £20,153 annual passive income on top of your State Pension?

Harvey Jones says the State Pension is nowhere near enough to fund a comfortable retirement, so you need to save…

Read more »

Smartly dressed middle-aged black gentleman working at his desk
Investing Articles

Near 5-year lows, here’s what the experts say about Greggs shares

Greggs’ shares went from a powerful growth story in 2024 to one of the FTSE 250’s worst-performing shares. Do experts…

Read more »

Investing Articles

How investing £20k in a Stocks and Shares ISA could generate a £15,815 yearly passive income for life

Harvey Jones shows how a single lump sum invested in a Stocks and Shares ISA can generate a high and…

Read more »

Investing Articles

Here are 3 cash-covered 7%-yielding FTSE 250 dividend shares with 30+ years of payouts

The FTSE 250 can be a minefield if you don't know what to look for. Mark Hartley breaks down his…

Read more »

Seniors having fun on bicycles in spring landscape
Investing Articles

With a 5.4% yield, 100 shares of this dividend stock could pay £250 of passive income

Our writer thinks this FTSE 250 bank stock still looks great value today, despite skyrocketing 303% over the past five…

Read more »

Landlady greets regular at real ale pub
Investing Articles

By mid-2027, analysts expect £10,000 in Diageo shares to be worth…

Diageo shares have tanked amid concerns over long-term demand for alcohol beverages. Is there the possibility of a rebound in…

Read more »

Wall Street sign in New York City
Investing Articles

UK investors are buying this stunning S&P 500 stock over Microsoft, Netflix and Nvidia. Why?

If you haven't heard of this S&P 500 growth stock yet, you soon will. British investors are keen but Harvey…

Read more »

Overjoyed exited middle aged married couple giving high five, finishing doing domestic paperwork together at home. Euphoric happy older mature spouses celebrating successful investment or purchase.
Investing Articles

How much do you need in an ISA to target a second income of £1,744 a month?

Harvey Jones shows how regular investing in FTSE 100 shares can build a generous second income for retirement, with minimum…

Read more »